-
Je něco špatně v tomto záznamu ?
A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report
M. Grofik, M. Cibulka, J. Olekšáková, M. Turčanová Koprušáková, T. Galanda, J. Necpál, P. Jungová, E. Kurča, J. Winkelmann, M. Zech, R. Jech
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu kazuistiky, časopisecké články
Grantová podpora
825575
lékařská fakulta Univerzity Karlovy
313011W875
Jessenius Faculty of Medicine (SK)
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-12-18
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- DNA vazebné proteiny genetika MeSH
- dystonické poruchy * genetika terapie MeSH
- dystonie * genetika terapie MeSH
- hluboká mozková stimulace * škodlivé účinky MeSH
- jaderné proteiny genetika MeSH
- lidé MeSH
- proteiny regulující apoptózu genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
BACKGROUND: DYT6 dystonia belongs to a group of isolated, genetically determined, generalized dystonia associated with mutations in the THAP1 gene. CASE PRESENTATION: We present the case of a young patient with DYT6 dystonia associated with a newly discovered c14G>A (p.Cys5Tyr) mutation in the THAP1 gene. We describe the clinical phenotype of this new mutation, effect of pallidal deep brain stimulation (DBS), which was accompanied by two rare postimplantation complications: an early intracerebral hemorrhage and delayed epileptic seizures. Among the published case reports of patients with DYT6 dystonia, the mentioned complications have not been described so far. CONCLUSIONS: DBS in the case of DYT6 dystonia is a challenge to thoroughly consider possible therapeutic benefits and potential risks associated with surgery. Genetic heterogeneity of the disease may also play an important role in predicting the development of the clinical phenotype as well as the effect of treatment including DBS. Therefore, it is beneficial to analyze the genetic and clinical relationships of DYT6 dystonia.
Department of Neurology Zvolen Hospital Zvolen Slovakia
Department of Neurosurgery Slovak Medical University and Roosevelt Hospital Banska Bystrica Slovakia
Institute of Human Genetics Technical University of Munich Munich Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024428
- 003
- CZ-PrNML
- 005
- 20241002104307.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12883-022-02871-3 $2 doi
- 035 __
- $a (PubMed)36096774
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Grofik, M $u Department of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin, Martin, Slovakia
- 245 12
- $a A case of novel DYT6 dystonia variant with serious complications after deep brain stimulation therapy: a case report / $c M. Grofik, M. Cibulka, J. Olekšáková, M. Turčanová Koprušáková, T. Galanda, J. Necpál, P. Jungová, E. Kurča, J. Winkelmann, M. Zech, R. Jech
- 520 9_
- $a BACKGROUND: DYT6 dystonia belongs to a group of isolated, genetically determined, generalized dystonia associated with mutations in the THAP1 gene. CASE PRESENTATION: We present the case of a young patient with DYT6 dystonia associated with a newly discovered c14G>A (p.Cys5Tyr) mutation in the THAP1 gene. We describe the clinical phenotype of this new mutation, effect of pallidal deep brain stimulation (DBS), which was accompanied by two rare postimplantation complications: an early intracerebral hemorrhage and delayed epileptic seizures. Among the published case reports of patients with DYT6 dystonia, the mentioned complications have not been described so far. CONCLUSIONS: DBS in the case of DYT6 dystonia is a challenge to thoroughly consider possible therapeutic benefits and potential risks associated with surgery. Genetic heterogeneity of the disease may also play an important role in predicting the development of the clinical phenotype as well as the effect of treatment including DBS. Therefore, it is beneficial to analyze the genetic and clinical relationships of DYT6 dystonia.
- 650 _2
- $a proteiny regulující apoptózu $x genetika $7 D051017
- 650 _2
- $a DNA vazebné proteiny $x genetika $7 D004268
- 650 12
- $a hluboká mozková stimulace $x škodlivé účinky $7 D046690
- 650 12
- $a dystonie $x genetika $x terapie $7 D004421
- 650 12
- $a dystonické poruchy $x genetika $x terapie $7 D020821
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jaderné proteiny $x genetika $7 D009687
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cibulka, M $u Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia. michal.cibulka@uniba.sk
- 700 1_
- $a Olekšáková, J $u Department of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin, Martin, Slovakia
- 700 1_
- $a Turčanová Koprušáková, M $u Department of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin, Martin, Slovakia
- 700 1_
- $a Galanda, T $u Department of Neurosurgery, Slovak Medical University and Roosevelt Hospital, Banska Bystrica, Slovakia
- 700 1_
- $a Necpál, J $u Department of Neurology, Zvolen Hospital, Zvolen, Slovakia
- 700 1_
- $a Jungová, P $u Department of Molecular and Biochemical Genetics - Centre of Rare Genetic Diseases, Faculty of Medicine & Comenius University, University Hospital Bratislava, Bratislava, Slovakia
- 700 1_
- $a Kurča, Egon, $d 1964- $7 nlk20050162662 $u Department of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava and University Hospital Martin, Martin, Slovakia
- 700 1_
- $a Winkelmann, J $u Institute of Neurogenomics, Helmholtz Centrum, Munich, Germany $u Institute of Human Genetics, Technical University of Munich, Munich, Germany
- 700 1_
- $a Zech, M $u Department of Molecular and Biochemical Genetics - Centre of Rare Genetic Diseases, Faculty of Medicine & Comenius University, University Hospital Bratislava, Bratislava, Slovakia $u Institute of Neurogenomics, Helmholtz Centrum, Munich, Germany
- 700 1_
- $a Jech, R $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00008195 $t BMC neurology $x 1471-2377 $g Roč. 22, č. 1 (2022), s. 344
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36096774 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20241002104303 $b ABA008
- 999 __
- $a ok $b bmc $g 1854250 $s 1175718
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 22 $c 1 $d 344 $e 20220912 $i 1471-2377 $m BMC neurology $n BMC Neurol $x MED00008195
- GRA __
- $a 825575 $p lékařská fakulta Univerzity Karlovy
- GRA __
- $a 313011W875 $p Jessenius Faculty of Medicine (SK)
- LZP __
- $a Pubmed-20221017